欧洲呼吸学会关于预防儿童喘的研究研讨会
Jonathan Grigg1,2, Benjamin Barratt3, Klaus Bønnelykke4
1Institute of Asthma and Allergy Prevention, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Pediatric pulmonology
|December 3, 2024
概括
减少孕妇和儿童的空气污染暴露,可以预防喘. 有前途的研究还表明,鱼油,原牛奶成分和免疫调节可能会预防喘的发展.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 环境健康 环境健康
- 免疫学 免疫学 免疫学
背景情况:
- 喘仍然是一个重要的全球健康问题,特别是在儿童中.
- 了解喘触发因素和预防策略对于公共卫生至关重要.
- 以前的研究强调了环境和遗传因素对喘发展的影响.
研究的目的:
- 总结欧洲呼吸学会关于预防喘的研究研讨会的主要发现.
- 审查与预防喘相关的流行病学和机制学研究.
- 确定未来喘预防研究的有希望的途径.
主要方法:
- 该报告是研究研讨会演讲的总结.
- 它综合了有关喘发病率的流行病学研究的发现.
- 还审查了探索生物途径的机制研究.
主要成果:
- 减少孕妇和儿童接触空气污染与较低的喘发病率有关.
- 鱼油和原牛奶的成分显示出预防喘的潜力.
- 通过模仿虫感染或微生物产品调节训练有素的免疫力是一个有前途的研究领域.
结论:
- 减少空气污染等环境干预措施对于预防喘至关重要.
- 像鱼油和特定的牛奶成分这样的饮食因素可能会对喘产生保护作用.
- 针对训练有素的免疫力,为预防喘提供了一种新且有前途的策略.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management
350
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
350
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
237
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
237


